Lechman, Eric R <br/><br/>
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.  [electronic resource] 

 -  Cancer cell  Feb 2016 
 - 214-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccell.2015.12.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Gene Knockdown Techniques<br/>Hematopoietic Stem Cells--pathology<br/>Heterografts<br/>Humans<br/>Leukemia, Myeloid, Acute--genetics<br/>Mice<br/>Mice, SCID<br/>MicroRNAs--genetics<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Prognosis<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>TOR Serine-Threonine Kinases--metabolism